Rock Creek Pharmaceuticals, Inc. announced that the company has made a key independent appointment to the company's board of directors with the recent election of Mr. Robert Scannell, as a new director, bringing the number of directors to five. Mr. Scannell is a professional private equity investor, portfolio manager and investment management firm founder. He is the Co-Founder and General Partner of IASO Advisors, LLC.

Prior to IASO Advisors, Mr. Scannell was Founder and General Partner of Tradewinds Investment Management, accumulating a 20-year record of success and $400 million of assets. Mr. Scannell began his financial career working with corporate and convertible bonds, high yield and emerging market debt at Merrill Lynch Capital Markets.